{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:51Z","timestamp":1786980291268,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00520-023-08258-5","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T03:04:05Z","timestamp":1703214245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk factors and clinical outcomes of cytomegalovirus diseases in hematologic malignancy patients without hematopoietic stem-cell transplantation"],"prefix":"10.1007","volume":"32","author":[{"given":"Jinyoung","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmin","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"8258_CR1","doi-asserted-by":"publisher","first-page":"703256","DOI":"10.3389\/fimmu.2021.703256","volume":"12","author":"S Alonso-\u00c1lvarez","year":"2021","unstructured":"Alonso-\u00c1lvarez S, Colado E, Moro-Garc\u00eda MA, Alonso-Arias R (2021) Cytomegalovirus in Haematological Tumours. Front Immunol. 12:703256. https:\/\/doi.org\/10.3389\/fimmu.2021.703256","journal-title":"Front Immunol."},{"issue":"5","key":"8258_CR2","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1172\/JCI45449","volume":"121","author":"M Boeckh","year":"2011","unstructured":"Boeckh M, Geballe AP (2011) Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest. 121(5):1673\u201380. https:\/\/doi.org\/10.1172\/JCI45449","journal-title":"J Clin Invest."},{"issue":"2","key":"8258_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.idc.2019.02.008","volume":"33","author":"A Pande","year":"2019","unstructured":"Pande A, Dubberke ER (2019) Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient. Infect Dis Clin North Am. 33(2):485\u2013500. https:\/\/doi.org\/10.1016\/j.idc.2019.02.008","journal-title":"Infect Dis Clin North Am."},{"issue":"9","key":"8258_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s1083-8791(03)00287-8","volume":"9","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 9(9):543\u201358. https:\/\/doi.org\/10.1016\/s1083-8791(03)00287-8","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"8258_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0268-960x(87)90037-3","volume":"1","author":"JA Barbara","year":"1987","unstructured":"Barbara JA, Tegtmeier GE (1987) Cytomegalovirus and blood transfusion. Blood Rev. 1(3):207\u201311. https:\/\/doi.org\/10.1016\/0268-960x(87)90037-3","journal-title":"Blood Rev."},{"issue":"12","key":"8258_CR6","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1182\/blood.v99.12.4357","volume":"99","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti S, Mackinnon S, Chopra R, Kottaridis PD, Peggs K, O\u2019Gorman P et al (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood. 99(12):4357\u201363. https:\/\/doi.org\/10.1182\/blood.v99.12.4357","journal-title":"Blood."},{"issue":"8","key":"8258_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ajh.21215","volume":"83","author":"YS Chae","year":"2008","unstructured":"Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Yang DH et al (2008) Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors. Am J Hematol. 83(8):649\u201353. https:\/\/doi.org\/10.1002\/ajh.21215","journal-title":"Am J Hematol."},{"issue":"12","key":"8258_CR8","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","volume":"94","author":"LA Holmberg","year":"1999","unstructured":"Holmberg LA, Boeckh M, Hooper H, Leisenring W, Rowley S, Heimfeld S et al (1999) Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 94(12):4029\u201335","journal-title":"Blood."},{"issue":"1","key":"8258_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G et al (2017) Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis. 64(1):87\u201391. https:\/\/doi.org\/10.1093\/cid\/ciw668","journal-title":"Clin Infect Dis."},{"issue":"6","key":"8258_CR10","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/cid\/ciu969","volume":"60","author":"JH Ko","year":"2015","unstructured":"Ko JH, Peck KR, Lee WJ, Lee JY, Cho SY, Ha YE et al (2015) Clinical presentation and risk factors for cytomegalovirus colitis in immunocompetent adult patients. Clin Infect Dis. 60(6):e20-6. https:\/\/doi.org\/10.1093\/cid\/ciu969","journal-title":"Clin Infect Dis."},{"issue":"4","key":"8258_CR11","doi-asserted-by":"publisher","first-page":"e23716","DOI":"10.1002\/jcla.23716","volume":"35","author":"R Choi","year":"2021","unstructured":"Choi R, Lee S, Lee SG, Lee EH (2021) Seroprevalence of CMV IgG and IgM in Korean women of childbearing age. J Clin Lab Anal. 35(4):e23716. https:\/\/doi.org\/10.1002\/jcla.23716","journal-title":"J Clin Lab Anal."},{"issue":"3","key":"8258_CR12","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.transproceed.2010.02.025","volume":"42","author":"JM Kim","year":"2010","unstructured":"Kim JM, Kim SJ, Joh JW, Kwon CH, Shin M, Kim EY et al (2010) Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas. Transplant Proc. 42(3):884\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2010.02.025","journal-title":"Transplant Proc."},{"issue":"4","key":"8258_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3947\/ic.2016.48.4.302","volume":"48","author":"SI Hong","year":"2016","unstructured":"Hong SI, Kim T, Park SY, Jung J, Lee JY, Chong YP et al (2016) Sensitivity of the Cytomegalovirus Antigenemia Assay to Diagnose Cytomegalovirus Retinitis. Infect Chemother. 48(4):302\u2013308. https:\/\/doi.org\/10.3947\/ic.2016.48.4.302","journal-title":"Infect Chemother."},{"issue":"2","key":"8258_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3947\/ic.2018.50.2.153","volume":"50","author":"JK Choi","year":"2018","unstructured":"Choi JK, Cho SY, Choi SM, Kim GH, Lee SE, Lee S et al (2018) Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review. Infect Chemother. 50(2):153\u2013159. https:\/\/doi.org\/10.3947\/ic.2018.50.2.153","journal-title":"Infect Chemother."},{"issue":"10","key":"8258_CR15","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/leu.2011.135","volume":"25","author":"A Kreutzman","year":"2011","unstructured":"Kreutzman A, Ladell K, Koechel C, Gostick E, Ekblom M, Stenke L et al (2011) Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation. Leukemia. 25(10):1587\u201397. https:\/\/doi.org\/10.1038\/leu.2011.135","journal-title":"Leukemia."}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08258-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08258-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08258-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:03:56Z","timestamp":1705363436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08258-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["8258"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08258-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the institutional review board of our institution (SMC 2022-06-099-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived due to the retrospective design of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}